Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5770006

CCOC(=O)CN1CCN(C(=O)CCc2cnoc2-c2ccc(F)cc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GAA P10253 2/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 3/20 0.36
CYP3A4 P08684 1/20 0.36
ALOX5 P09917 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP7 Q9UHL4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5776847 0.89 MDM2 (0.39) ALDH1A1L3MBTL1MAPTHTTTSHR
Trifluoroacetic Acid SCHEMBL5776834 0.85 HTT (0.46) MAPTHTTLMNASMN1; SMN2ALOX5
Trifluoroacetic Acid SCHEMBL5772964 0.85 TSHR (0.45) KDM4ETSHRCYP3A4ALOX5MEN1
Trifluoroacetic Acid SCHEMBL5776822 0.83 DPP8 (0.50) ALDH1A1MAPTHTTTSHRALOX5
Trifluoroacetic Acid SCHEMBL5777433 0.83 GFER (0.53) ALDH1A1HSD17B10GAAMAPTLMNA
Trifluoroacetic Acid SCHEMBL5770010 0.82 HTR1A (0.49) KDM4EALDH1A1HSD17B10L3MBTL1MAPT
SCHEMBL5907061 0.81 HTR2A (0.39) MAPTHTTLMNASMN1; SMN2ALOX5
Trifluoroacetic Acid SCHEMBL5773395 0.81 LMNA (0.48) KDM4EALDH1A1GAAMAPTLMNA
Trifluoroacetic Acid SCHEMBL5773386 0.81 LMNA (0.48) KDM4EALDH1A1GAAMAPTLMNA
Trifluoroacetic Acid SCHEMBL5772610 0.81 GFER (0.53) MAPTLMNATSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR KDM4E 3953/4885ALDH1A1 1045/4885ALOX15 577/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 KDM4E 3347/4885ALDH1A1 682/4885ALOX15 800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.